Gossamer Bio, Inc. (GOSS)
9.76
+0.48
(+5.17%)
USD |
NASDAQ |
Oct 13, 16:00
9.94
+0.18
(+1.84%)
After-Hours: 05:51
Gossamer Bio EPS Diluted (TTM) : -55.67 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.67 |
| March 31, 2026 | -63.01 |
| December 31, 2025 | -59.99 |
| September 30, 2025 | -54.98 |
| June 30, 2025 | -48.94 |
| March 31, 2025 | -18.96 |
| December 31, 2024 | -20.90 |
| September 30, 2024 | -26.32 |
| June 30, 2024 | -32.03 |
| March 31, 2024 | -84.16 |
| December 31, 2023 | -110.76 |
| September 30, 2023 | -140.99 |
| June 30, 2023 | -176.48 |
| March 31, 2023 | -199.78 |
| December 31, 2022 | -219.23 |
| September 30, 2022 | -231.48 |
| June 30, 2022 | -243.66 |
| March 31, 2022 | -248.84 |
| Date | Value |
|---|---|
| December 31, 2021 | -250.17 |
| September 30, 2021 | -261.19 |
| June 30, 2021 | -260.95 |
| March 31, 2021 | -277.17 |
| December 31, 2020 | -284.83 |
| September 30, 2020 | -285.64 |
| June 30, 2020 | -285.49 |
| March 31, 2020 | -264.23 |
| December 31, 2019 | -266.17 |
| September 30, 2019 | -241.88 |
| June 30, 2019 | -238.02 |
| March 31, 2019 | -218.71 |
| December 31, 2018 | -178.49 |
| September 30, 2018 | -139.21 |
| June 30, 2018 | -79.56 |
| March 31, 2018 | -39.80 |
| December 31, 2017 | -8.184 |
| September 30, 2017 | -0.3496 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| United Therapeutics Corp. | 27.96 |
| Arbutus Biopharma Corp. | 0.7834 |
| Kura Oncology, Inc. | -3.362 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |